Public Employees Retirement Association of Colorado’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-9,008
Closed -$32K 1928
2024
Q3
$32K Hold
9,008
﹤0.01% 1901
2024
Q2
$30K Hold
9,008
﹤0.01% 1892
2024
Q1
$66K Sell
9,008
-1,803
-17% -$11.2K ﹤0.01% 1814
2023
Q4
$40K Hold
10,811
﹤0.01% 1872
2023
Q3
$23K Hold
10,811
﹤0.01% 1909
2023
Q2
$51K Hold
10,811
﹤0.01% 1885
2023
Q1
$62K Hold
10,811
﹤0.01% 1871
2022
Q4
$109K Hold
10,811
﹤0.01% 1770
2022
Q3
$242K Hold
10,811
﹤0.01% 1470
2022
Q2
$268K Hold
10,811
﹤0.01% 1451
2022
Q1
$419K Hold
10,811
﹤0.01% 1249
2021
Q4
$633K Hold
10,811
﹤0.01% 1049
2021
Q3
$641K Hold
10,811
﹤0.01% 1022
2021
Q2
$938K Hold
10,811
﹤0.01% 830
2021
Q1
$891K Hold
10,811
﹤0.01% 841
2020
Q4
$983K Hold
10,811
﹤0.01% 756
2020
Q3
$432K Hold
10,811
﹤0.01% 1056
2020
Q2
$371K Hold
10,811
﹤0.01% 1138
2020
Q1
$240K Buy
+10,811
New +$273K ﹤0.01% 1258

Other funds holding FATE

Public Employees Retirement Association of Colorado's FATE Position: Q4 2024 in Review

Public Employees Retirement Association of Colorado sold out of Fate Therapeutics (FATE) in Q4 2024, closing a stake of 9,008 shares — an estimated $32K sold.

Public Employees Retirement Association of Colorado first reported a position in FATE in Q1 2020 and held it in 19 quarters. The position peaked at $983K in Q4 2020. 159 funds tracked by Wall St. Rank hold FATE as of Q4 2024.

  • Public Employees Retirement Association of Colorado reported no remaining Fate Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Public Employees Retirement Association of Colorado sold 9,008 Fate Therapeutics shares in Q4 2024, an estimated $32K.
  • Public Employees Retirement Association of Colorado first reported a position in Fate Therapeutics in Q1 2020 and held it in 19 quarters.
  • Public Employees Retirement Association of Colorado's Fate Therapeutics position peaked at $983K in Q4 2020.
  • 159 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2024.

Based on Public Employees Retirement Association of Colorado's 13F filing for Q4 2024, filed 14 Feb 2025.